SEP 15, 2015 07:59 AM PDT

Merging Immunotherapy and Epigenetic Therapy To Defeat Cancer

WRITTEN BY: Kara Marker
Today, a review from Clinical Cancer Research, a journal of the American Association for Cancer Research brought to light a new potential weapon for the fight against cancer. Together, epigenetic therapy and immunotherapy could be the key to killing cancerous cells. Since there are so many kinds of cancer that target different parts of the body in different ways, the fight against cancer has been slow and full of obstacles. However, combining these two therapies in the right way could be effective in treating cancer of many types.


In the words of Michele Maio, MD, PhD, chair of medical oncology and immunotherapy, Ospedale Santa Maria alle Scotte, Istituto Toscano Tumori, in Siena, Italy, epigenetics is the study of "cellular changes in gene expression." For example, a person could have the DNA necessary to make a certain gene, but if their epigenetic code is not programmed to turn on production of this gene, it is as if the DNA is not even there. Our gene expression is inherited from our parents, and this family connection could also explain why some people have a genetic predisposition for some types of cancer.

Maio stresses the importance of clarifying that epigenetic differences are not the same as a genetic mutation. Rather, methylation of DNA causes certain strands of genetic code to be inactivated (Nature). Fortunately, as research into the mechanics of epigenetics has provided scientists with more information on how to manipulate gene expression, recently cancer experts have been able to utilize epigenetic therapy to uniquely treat cancer patients.


In some cancer patients, uncontrollable cell growth occurs because gene expression for immune cells that recognize cancerous growth is being suppressed. If these necessary regulatory cells are not being produced, cancerous cells will grow uncontrollably, undetected and unregulated. However, using epigenetic therapy to turn expression of these immune cells back on could help the immune system detect and stop cancer cell growth all on its own. 

In addition, epigenetic therapy can be used to suppress gene expression of immune cells that instigate cancer cell growth, such as myeloid-derived suppressor cells (MDSCs). Normally, in a healthy individual these cells consist of infection-fighting granulocytes, macrophages, and dendritic cells. However, in a cancerous or other pathological situation, these cells are blocked from differentiating, remain in their immature form, and can contribute to the upregulation of immune suppressors (Nature Reviews Immunology). 

Currently, Maio and his team are running clinical trials to test different combinations of immunotherapy and epigenetic therapy with different kinds of cancers to find a perfect match of treatment with which to use on various cancer patients.The future of this combination treatment is bright, but the scientists do have to keep in mind the potential negative side effect of myelotoxicity. Myeloid tissues make blood cells, and overwhelming these tissues with chemicals could harm regular hematopoiesis. 

Back in February, John Hopkins Medicine explained how they used epigenetic therapy to fight cancer. As explained by surgeon and oncologist Dr. Malcolm Brock, they transformed cancerous cells into healthy cells to make them easier targets by chemotherapy. Watch the video below to hear Dr. Brock explain how they did this. 


Source: EurekAlert and The American Association for Cancer Research 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 17, 2019
Immunology
SEP 17, 2019
Graphene and Health Impacts
The Graphene Flagship project is a dedicated Work Package studying the impact of graphene and related materials on health, as well as their environmental impact....
SEP 17, 2019
Immunology
SEP 17, 2019
Heating Up on the Flu
Climate change may affect the future of vaccinations and nutrition....
SEP 17, 2019
Cancer
SEP 17, 2019
Widely Prescribed Breast Cancer Medication Promotes Metastasis
The primary goals of metastatic breast cancer treatment are to ensure that the patient has the longest survival possible while experiencing the highes...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Toxic Air is Shortening Children's Lifespans
According to the State of Global Air 2019 report, air pollution is currently shortening life expectancy by an average of 20 months worldwide. This means th...
SEP 17, 2019
Microbiology
SEP 17, 2019
Gut Microbes may Link Stress and Autoimmune Disease
Stress can have a detrimental effect on our health, and appears to contribute to the development of autoimmune diseases....
SEP 17, 2019
Immunology
SEP 17, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
Loading Comments...